NCT05204342|Completed
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
Pro-TOCa
Loading search results
Pro-TOCa
Sponsor study identifier
observational
22,500
1 country
1
Study Start
January 1, 2012
Actual (reported)Primary Completion
December 30, 2021
Actual (reported)Study Completion
December 30, 2021
Actual (reported)Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 30, 2021
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2012
Actual (reported)December 30, 2021
Actual (reported)December 30, 2021
Actual (reported)January 10, 2022
Actual (reported)January 24, 2022
Actual (reported)To study the prognostic effect of the volume of activity
To study the prognostic effect of the volume of activity per center on the risk of recurrence
at 5 years
Verify that the therapeutic sequence
Verify that the therapeutic sequence of primary surgery and secondary chemotherapy is a good prognostic factor for overall and specific survival at 5 years
at 5 years
Verify that delay in initiation of chemotherapy beyond 4 weeks
at 5 years
Verify that age is a poor prognostic element
at 5 years
Verify that geographic distance
at 5 years
Women treated for tubo-ovarian cancer in France between 2012 and 2016
Uhmontpellier
Montpellier, 34295, France
Martha DURAES, Md
University Hospital, Montpellier
22,500 participants (actual enrollment reported by the registry).
First Submitted
January 10, 2022
First Posted
January 24, 2022
Study Start
January 1, 2012
Actual (reported)Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)
Contact the study team to confirm eligibility.
Primary Completion
December 30, 2021
Actual (reported)Study Completion
December 30, 2021
Actual (reported)Last Updated
January 24, 2022
Record last verified: 2022-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: